Signal transmission through the CXC chemokine receptor 4 (CXCR4) transmembrane helices
暂无分享,去创建一个
T. Handel | I. Kufareva | J. Rucker | B. Puffer | C. Paes | B. Doranz | E. Berdougo | Melanie P. Wescott | Jason R. Goodman | Yana Thaker | Cheryl Paes
[1] Bas Vroling,et al. GPCRdb: an information system for G protein-coupled receptors , 2015, Nucleic Acids Res..
[2] Stephen M. Husbands,et al. Structural insights into μ-opioid receptor activation , 2015, Nature.
[3] Melinda S. Hanes,et al. Dual Targeting of the Chemokine Receptors CXCR4 and ACKR3 with Novel Engineered Chemokines* , 2015, The Journal of Biological Chemistry.
[4] Irina Kufareva,et al. Chemokine and chemokine receptor structure and interactions: implications for therapeutic strategies , 2015, Immunology and cell biology.
[5] Ruben Abagyan,et al. Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine , 2015, Science.
[6] R. Abagyan,et al. Stoichiometry and geometry of the CXC chemokine receptor 4 complex with CXC ligand 12: Molecular modeling and experimental validation , 2014, Proceedings of the National Academy of Sciences.
[7] E. Davidson,et al. A high‐throughput shotgun mutagenesis approach to mapping B‐cell antibody epitopes , 2014, Immunology.
[8] Hualiang Jiang,et al. Structure of the CCR5 Chemokine Receptor–HIV Entry Inhibitor Maraviroc Complex , 2013, Science.
[9] D. Guo,et al. Biased and Constitutive Signaling in the CC-chemokine Receptor CCR5 by Manipulating the Interface between Transmembrane Helices 6 and 7* , 2013, The Journal of Biological Chemistry.
[10] Nouri Neamati,et al. Small Molecule Inhibitors of CXCR4 , 2013, Theranostics.
[11] R. Stevens,et al. Structure-function of the G protein-coupled receptor superfamily. , 2013, Annual review of pharmacology and toxicology.
[12] W. Boisvert,et al. Leu1283.43 (L128) and Val2476.40 (V247) of CXCR1 Are Critical Amino Acid Residues for G Protein Coupling and Receptor Activation , 2012, PloS one.
[13] Vadim Cherezov,et al. Diversity and modularity of G protein-coupled receptor structures. , 2012, Trends in pharmacological sciences.
[14] Xavier Deupi,et al. Stabilized G protein binding site in the structure of constitutively active metarhodopsin-II , 2011, Proceedings of the National Academy of Sciences.
[15] Xavier Deupi,et al. Structural insights into agonist-induced activation of G-protein-coupled receptors. , 2011, Current opinion in structural biology.
[16] S. Rasmussen,et al. Crystal Structure of the β2Adrenergic Receptor-Gs protein complex , 2011, Nature.
[17] R. Stevens,et al. Structure of an Agonist-Bound Human A2A Adenosine Receptor , 2011, Science.
[18] Oliver P. Ernst,et al. Crystal structure of metarhodopsin II , 2011, Nature.
[19] Gebhard F. X. Schertler,et al. The structural basis of agonist-induced activation in constitutively active rhodopsin , 2011, Nature.
[20] J. Tesmer,et al. Recognition in the Face of Diversity: Interactions of Heterotrimeric G proteins and G Protein-coupled Receptor (GPCR) Kinases with Activated GPCRs* , 2011, The Journal of Biological Chemistry.
[21] S. Rasmussen,et al. Structure of a nanobody-stabilized active state of the β2 adrenoceptor , 2010, Nature.
[22] R. Abagyan,et al. Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists , 2010, Science.
[23] P. Reeves,et al. Highly conserved tyrosine stabilizes the active state of rhodopsin , 2010, Proceedings of the National Academy of Sciences.
[24] Thomas M Frimurer,et al. A Conserved Aromatic Lock for the Tryptophan Rotameric Switch in TM-VI of Seven-transmembrane Receptors* , 2009, The Journal of Biological Chemistry.
[25] P. Scheerer,et al. A G protein-coupled receptor at work: the rhodopsin model. , 2009, Trends in biochemical sciences.
[26] Hideo Takahashi,et al. Structural Basis of the Interaction between Chemokine Stromal Cell-derived Factor-1/CXCL12 and Its G-protein-coupled Receptor CXCR4* , 2009, The Journal of Biological Chemistry.
[27] J. Rucker,et al. Atomic-level mapping of antibody epitopes on a GPCR. , 2009, Journal of the American Chemical Society.
[28] R. Wong,et al. Comparison of the Potential Multiple Binding Modes of Bicyclam, Monocylam, and Noncyclam Small-Molecule CXC Chemokine Receptor 4 Inhibitors , 2008, Molecular Pharmacology.
[29] Xavier Deupi,et al. Activation of G protein-coupled receptors. , 2007, Advances in protein chemistry.
[30] C. Combs,et al. Dimerization of CXCR4 in living malignant cells: control of cell migration by a synthetic peptide that reduces homologous CXCR4 interactions , 2006, Molecular Cancer Therapeutics.
[31] Won-Tak Choi,et al. Unique Ligand Binding Sites on CXCR4 Probed by a Chemical Biology Approach: Implications for the Design of Selective Human Immunodeficiency Virus Type 1 Inhibitors , 2005, Journal of Virology.
[32] Won-Tak Choi,et al. Distinct Functional Sites for Human Immunodeficiency Virus Type 1 and Stromal Cell-Derived Factor 1α on CXCR4 Transmembrane Helical Domains , 2005, Journal of Virology.
[33] Mette M. Rosenkilde,et al. Molecular Mechanism of AMD3100 Antagonism in the CXCR4 Receptor , 2004, Journal of Biological Chemistry.
[34] Gert Vriend,et al. GPCRDB information system for G protein-coupled receptors , 2003, Nucleic Acids Res..
[35] Francesca Fanelli,et al. Mutagenesis and modelling of the alpha(1b)-adrenergic receptor highlight the role of the helix 3/helix 6 interface in receptor activation. , 2002, Molecular pharmacology.
[36] Zhaowen Luo,et al. Structural and Functional Characterization of Human CXCR4 as a Chemokine Receptor and HIV-1 Co-receptor by Mutagenesis and Molecular Modeling Studies* , 2001, The Journal of Biological Chemistry.
[37] N. Heveker,et al. Identification of Residues of CXCR4 Critical for Human Immunodeficiency Virus Coreceptor and Chemokine Receptor Activities* , 2000, The Journal of Biological Chemistry.
[38] Stephen C. Peiper,et al. Identification of CXCR4 Domains That Support Coreceptor and Chemokine Receptor Functions , 1999, Journal of Virology.
[39] B. Sykes,et al. Solution structure and basis for functional activity of stromal cell‐derived factor‐1; dissociation of CXCR4 activation from binding and inhibition of HIV‐1 , 1997, The EMBO journal.
[40] H Weinstein,et al. Agonists induce conformational changes in transmembrane domains III and VI of the β2 adrenoceptor , 1997, The EMBO journal.
[41] N. Heveker,et al. Role of the first and third extracellular domains of CXCR-4 in human immunodeficiency virus coreceptor activity , 1997, Journal of virology.
[42] H. Khorana,et al. Requirement of Rigid-Body Motion of Transmembrane Helices for Light Activation of Rhodopsin , 1996, Science.